After release of Covaxin’s phase 3 efficacy data, NTAGI chief says it will help vaccine get WHO recognition

By Shalini Bhardwaj New Delhi [India], (ANI): Hours after Bharat Biotech announced that its vaccine Covaxin's efficacy against COVID-19 is 77.8 per cent, National Technical Advisory Group on Immunisation (NTAGI)…